Gasbi, Aljan .
HRN: 22-86-53 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/13/2023
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
04/13/2023
04/15/2023
PO
2.5ml
BID
Intestinal Parasitism
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes